Cargando...
Dapagliflozin in Patients with Chronic Heart Failure: A Systematic Review and Meta-Analysis
Sodium-glucose cotransporter-2 (SGLT2) inhibitors represent newly developed oral antidiabetic drugs that are practiced for type 2 diabetes mellitus management and may decrease the risk of the first hospitalization in heart failure. The activity of SGLT2 inhibitors is not related to glucose, and the...
Gardado en:
| Publicado en: | Cardiol Res Pract |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8026320/ https://ncbi.nlm.nih.gov/pubmed/33859839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6657380 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|